NZ263008A - Preparation of optionally bridged 5,6,7,8-tetrahydro-1h-1,3,4a,8a-tetraaza-cyclopentanaphthalene-4,9-dione derivatives by selective reduction of the corresponding - Google Patents

Preparation of optionally bridged 5,6,7,8-tetrahydro-1h-1,3,4a,8a-tetraaza-cyclopentanaphthalene-4,9-dione derivatives by selective reduction of the corresponding

Info

Publication number
NZ263008A
NZ263008A NZ263008A NZ26300894A NZ263008A NZ 263008 A NZ263008 A NZ 263008A NZ 263008 A NZ263008 A NZ 263008A NZ 26300894 A NZ26300894 A NZ 26300894A NZ 263008 A NZ263008 A NZ 263008A
Authority
NZ
New Zealand
Prior art keywords
group
lower alkyl
hydrogen atom
formula
alkyl group
Prior art date
Application number
NZ263008A
Other languages
English (en)
Inventor
Hiroyoshi Yamada
Kiyotaka Munesada
Keiko Koh
Mikio Taniguchi
Yoshiji Fujita
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NZ263008A publication Critical patent/NZ263008A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ263008A 1993-03-19 1994-03-04 Preparation of optionally bridged 5,6,7,8-tetrahydro-1h-1,3,4a,8a-tetraaza-cyclopentanaphthalene-4,9-dione derivatives by selective reduction of the corresponding NZ263008A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5060067A JPH06271576A (ja) 1993-03-19 1993-03-19 イミダゾール誘導体の製法

Publications (1)

Publication Number Publication Date
NZ263008A true NZ263008A (en) 1996-12-20

Family

ID=13131379

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ263008A NZ263008A (en) 1993-03-19 1994-03-04 Preparation of optionally bridged 5,6,7,8-tetrahydro-1h-1,3,4a,8a-tetraaza-cyclopentanaphthalene-4,9-dione derivatives by selective reduction of the corresponding

Country Status (7)

Country Link
EP (1) EP0689544A1 (zh)
JP (2) JPH06271576A (zh)
CN (1) CN1120337A (zh)
AU (1) AU6351994A (zh)
CA (1) CA2155573A1 (zh)
NZ (1) NZ263008A (zh)
WO (1) WO1994021641A1 (zh)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2098403T3 (es) * 1991-09-10 1997-05-01 Tanabe Seiyaku Co Derivados de la imidazoindolizina y procedimiento para su preparacion.
JPH06107661A (ja) * 1991-10-24 1994-04-19 Upjohn Co:The イミダゾール誘導体およびこれを有効成分とする医薬組成物

Also Published As

Publication number Publication date
WO1994021641A1 (en) 1994-09-29
CN1120337A (zh) 1996-04-10
CA2155573A1 (en) 1994-09-29
JPH06271576A (ja) 1994-09-27
AU6351994A (en) 1994-10-11
JPH08508468A (ja) 1996-09-10
EP0689544A1 (en) 1996-01-03

Similar Documents

Publication Publication Date Title
AU685939B2 (en) DC-89 derivative
JP4172717B2 (ja) 置換２，５−ジアミノ−３−ヒドロキシヘキサンの製造方法
US7799930B2 (en) 1-alkyl-3-aminoindazoles
JP2008515952A (ja) ４−（３−スルホニルフェニル）−ピペリジンの合成方法
JP3192027B2 (ja) ２−ホルミルピリジンチオセミカルバゾン抗腫瘍剤
WO1996030348A1 (en) Synthesis of bis-indolylmaleimides
BG64701B1 (bg) Метод за получаване на 2-азадихидроксибицикло[2.2.1]хептаново съединение и сол на съединението и l-винена киселина
NZ263008A (en) Preparation of optionally bridged 5,6,7,8-tetrahydro-1h-1,3,4a,8a-tetraaza-cyclopentanaphthalene-4,9-dione derivatives by selective reduction of the corresponding
FR2459799A1 (fr) Synthese de la ()-vincamine
JP3831954B2 (ja) ４−ヒドロキシ−２−ピロリドンの製法
KR20150066777A (ko) 광학활성 인돌린 유도체 및 이의 제조방법
IE920495A1 (en) New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
CA2331758C (en) Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
WO2024015861A1 (en) Methods of preparation of heterocyclic compounds
JP2569358B2 (ja) 新規化合物
JP3315007B2 (ja) ピリジルオキシブチニルアミン誘導体
WO2024093091A1 (zh) 一种海鞘素类化合物中间体的制备方法
JP2001002679A (ja) テトラヒドロチエノイミダゾール誘導体及びその製法
FR2475549A1 (fr) Derives vincaminiques desethyles, leur synthese et leur application en therapeutique
CZ286483B6 (en) Derivatives of 2-azabicyclo/2,2,1/heptane and process of their preparation
JP2003192651A (ja) ３−アミノカルボン酸およびそのエステルの製法
JPS62153271A (ja) インド−ル類の製造方法
GB2152036A (en) 4,5,6,7-Tetrahydrobenzimidazole derivatives